UPC_CFI_504/2023

Intravenous infusion system with dosing device

InfringementMain Infringement ActionDusseldorf LDInfringementCase ClosedSettled at: Pre-merits

Overview Decisions Reasoning Citations Documents Timeline

Parties

Claimants

F. Hoffman-La Roche AG(Roche Group)

Reps: Christof Augenstein (Kather Augenstein Rechtsanwälte PartGmbB); Sophie Prudent (Kather Augenstein Rechtsanwälte PartGmbB); Katharina Brandt (Kather Augenstein Rechtsanwälte PartGmbB)

Respondents

Tandem Diabetes Care, Inc.
Tandem Diabetes Care Europe B.V.
VitalAire GmbH
Dinno Santé s.a.i.
Air Liquide Healthcare Nederland B.V.
Rubin Medical ApS, c/o Diatom A/S

Reps: Roland Küppers (Taylor Wessing Partnerschaftsgesellschaft mbB); Alexander Rubusch (Taylor Wessing Partnerschaftsgesellschaft mbB); Christine Kanz (Hoyng Rokh Monegier); Tung-Gia du (Hoyng Rokh Monegier)

Judges

Ronny Thomas
Jule Schumacher
Margot Kokke
Christoph Schober

Patents

EP1970677
EP 1 970 677 B1

CPC codes: A61M5/168, A61M5/16854, A61M5/152, A61M2205/3379, A61M5/14216, A61M5/14, F04B53/162, A61M5/31525, A61M2005/16863, A61M5/16859, A61M5/16881, A61M5/16809…

Technology area: Medical Devices · Implants

Sector: Measurement & Testing

Outcome

SettledSettled (pre-decision)

Filed: Jan 2, 2024

First decided: —

Language: German

Settled at: Pre-merits — settled commercially

The court confirmed a partial settlement between the claimants (Roche) and defendants 1 and 2 (Tandem Diabetes Care Inc. and Tandem Diabetes Care Europe B.V.) pursuant to Rule 365.1 RoP. The details of the settlement are confidential. Proceedings against defendants 3 to 6 continue. Each settling party bears its own costs.

Open on UPC Registry